The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Chronic Pain Treatment-Global Market Insights and Sales Trends 2025
Synopsis
Chronic pain is pain that carries on for longer than 12 weeks despite medication or treatment. Most people get back to normal after pain following an injury or operation. But sometimes the pain carries on for longer or comes on without any history of an injury or operation.
The global Chronic Pain Treatment market size is expected to reach US$ 126790 million by 2029, growing at a CAGR of 6.7% from 2023 to 2029. The market is mainly driven by the significant applications of Chronic Pain Treatment in various end use industries. The expanding demands from the Hospitals, Clinics, Nursing Homes and Research Centers, are propelling Chronic Pain Treatment market. Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Devices segment is estimated at % CAGR for the next seven-year period.
According to the World Health Organization (WHO), between 2015 and 2050, the proportion of the world's population over the age of 60 will nearly double, from 12% to 22%. In addition, the prevalence of chronic pain in nursing home seniors is very high and has become a serious problem in nursing facilities. Globally, rising prevalence of chronic diseases is one of the major healthcare burdens, affecting high-income as well as low- and middle-income countries. Due to the increasing prevalence of chronic diseases, various treatments such as medication, physical therapy, and psychotherapy are widely used through which pain can be managed.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Chronic Pain Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Chronic Pain Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Chronic Pain Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Chronic Pain Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Chronic Pain Treatment covered in this report include Eli Lilly and Company, GlaxoSmithKline, Pfizer, Medtronic, Abbott Laboratories, Boston Scientific Corporation, Novartis AG, Johnson & Johnson and AstraZeneca PLC, etc.
The global Chronic Pain Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eli Lilly and Company
GlaxoSmithKline
Pfizer
Medtronic
Abbott Laboratories
Boston Scientific Corporation
Novartis AG
Johnson & Johnson
AstraZeneca PLC
Bristol-Myers Squibb
Becton, Dickinson and Company
Sanofi
Global Chronic Pain Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Chronic Pain Treatment market, Segment by Type:
Drugs
Devices
Global Chronic Pain Treatment market, by Application
Hospitals
Clinics
Nursing Homes
Research Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Chronic Pain Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Chronic pain is pain that carries on for longer than 12 weeks despite medication or treatment. Most people get back to normal after pain following an injury or operation. But sometimes the pain carries on for longer or comes on without any history of an injury or operation.
The global Chronic Pain Treatment market size is expected to reach US$ 126790 million by 2029, growing at a CAGR of 6.7% from 2023 to 2029. The market is mainly driven by the significant applications of Chronic Pain Treatment in various end use industries. The expanding demands from the Hospitals, Clinics, Nursing Homes and Research Centers, are propelling Chronic Pain Treatment market. Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Devices segment is estimated at % CAGR for the next seven-year period.
According to the World Health Organization (WHO), between 2015 and 2050, the proportion of the world's population over the age of 60 will nearly double, from 12% to 22%. In addition, the prevalence of chronic pain in nursing home seniors is very high and has become a serious problem in nursing facilities. Globally, rising prevalence of chronic diseases is one of the major healthcare burdens, affecting high-income as well as low- and middle-income countries. Due to the increasing prevalence of chronic diseases, various treatments such as medication, physical therapy, and psychotherapy are widely used through which pain can be managed.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Chronic Pain Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Chronic Pain Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Chronic Pain Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Chronic Pain Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Chronic Pain Treatment covered in this report include Eli Lilly and Company, GlaxoSmithKline, Pfizer, Medtronic, Abbott Laboratories, Boston Scientific Corporation, Novartis AG, Johnson & Johnson and AstraZeneca PLC, etc.
The global Chronic Pain Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eli Lilly and Company
GlaxoSmithKline
Pfizer
Medtronic
Abbott Laboratories
Boston Scientific Corporation
Novartis AG
Johnson & Johnson
AstraZeneca PLC
Bristol-Myers Squibb
Becton, Dickinson and Company
Sanofi
Global Chronic Pain Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Chronic Pain Treatment market, Segment by Type:
Drugs
Devices
Global Chronic Pain Treatment market, by Application
Hospitals
Clinics
Nursing Homes
Research Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Chronic Pain Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Chronic Pain Treatment
1.1 Chronic Pain Treatment Market Overview
1.1.1 Chronic Pain Treatment Product Scope
1.1.2 Chronic Pain Treatment Market Status and Outlook
1.2 Global Chronic Pain Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Chronic Pain Treatment Market Size by Region (2018-2029)
1.4 Global Chronic Pain Treatment Historic Market Size by Region (2018-2023)
1.5 Global Chronic Pain Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Chronic Pain Treatment Market Size (2018-2029)
1.6.1 North America Chronic Pain Treatment Market Size (2018-2029)
1.6.2 Europe Chronic Pain Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Chronic Pain Treatment Market Size (2018-2029)
1.6.4 Latin America Chronic Pain Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Chronic Pain Treatment Market Size (2018-2029)
2 Chronic Pain Treatment Market by Type
2.1 Introduction
2.1.1 Drugs
2.1.2 Devices
2.2 Global Chronic Pain Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Chronic Pain Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Chronic Pain Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Chronic Pain Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Chronic Pain Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Chronic Pain Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Chronic Pain Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Chronic Pain Treatment Revenue Breakdown by Type (2018-2029)
3 Chronic Pain Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Nursing Homes
3.1.4 Research Centers
3.2 Global Chronic Pain Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Chronic Pain Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Chronic Pain Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Chronic Pain Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Chronic Pain Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Chronic Pain Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Chronic Pain Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Chronic Pain Treatment Revenue Breakdown by Application (2018-2029)
4 Chronic Pain Treatment Competition Analysis by Players
4.1 Global Chronic Pain Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chronic Pain Treatment as of 2022)
4.3 Date of Key Players Enter into Chronic Pain Treatment Market
4.4 Global Top Players Chronic Pain Treatment Headquarters and Area Served
4.5 Key Players Chronic Pain Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Chronic Pain Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Eli Lilly and Company
5.1.1 Eli Lilly and Company Profile
5.1.2 Eli Lilly and Company Main Business
5.1.3 Eli Lilly and Company Chronic Pain Treatment Products, Services and Solutions
5.1.4 Eli Lilly and Company Chronic Pain Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Eli Lilly and Company Recent Developments
5.2 GlaxoSmithKline
5.2.1 GlaxoSmithKline Profile
5.2.2 GlaxoSmithKline Main Business
5.2.3 GlaxoSmithKline Chronic Pain Treatment Products, Services and Solutions
5.2.4 GlaxoSmithKline Chronic Pain Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 GlaxoSmithKline Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Chronic Pain Treatment Products, Services and Solutions
5.3.4 Pfizer Chronic Pain Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Medtronic Recent Developments
5.4 Medtronic
5.4.1 Medtronic Profile
5.4.2 Medtronic Main Business
5.4.3 Medtronic Chronic Pain Treatment Products, Services and Solutions
5.4.4 Medtronic Chronic Pain Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Medtronic Recent Developments
5.5 Abbott Laboratories
5.5.1 Abbott Laboratories Profile
5.5.2 Abbott Laboratories Main Business
5.5.3 Abbott Laboratories Chronic Pain Treatment Products, Services and Solutions
5.5.4 Abbott Laboratories Chronic Pain Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Abbott Laboratories Recent Developments
5.6 Boston Scientific Corporation
5.6.1 Boston Scientific Corporation Profile
5.6.2 Boston Scientific Corporation Main Business
5.6.3 Boston Scientific Corporation Chronic Pain Treatment Products, Services and Solutions
5.6.4 Boston Scientific Corporation Chronic Pain Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Boston Scientific Corporation Recent Developments
5.7 Novartis AG
5.7.1 Novartis AG Profile
5.7.2 Novartis AG Main Business
5.7.3 Novartis AG Chronic Pain Treatment Products, Services and Solutions
5.7.4 Novartis AG Chronic Pain Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Novartis AG Recent Developments
5.8 Johnson & Johnson
5.8.1 Johnson & Johnson Profile
5.8.2 Johnson & Johnson Main Business
5.8.3 Johnson & Johnson Chronic Pain Treatment Products, Services and Solutions
5.8.4 Johnson & Johnson Chronic Pain Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Johnson & Johnson Recent Developments
5.9 AstraZeneca PLC
5.9.1 AstraZeneca PLC Profile
5.9.2 AstraZeneca PLC Main Business
5.9.3 AstraZeneca PLC Chronic Pain Treatment Products, Services and Solutions
5.9.4 AstraZeneca PLC Chronic Pain Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 AstraZeneca PLC Recent Developments
5.10 Bristol-Myers Squibb
5.10.1 Bristol-Myers Squibb Profile
5.10.2 Bristol-Myers Squibb Main Business
5.10.3 Bristol-Myers Squibb Chronic Pain Treatment Products, Services and Solutions
5.10.4 Bristol-Myers Squibb Chronic Pain Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Bristol-Myers Squibb Recent Developments
5.11 Becton, Dickinson and Company
5.11.1 Becton, Dickinson and Company Profile
5.11.2 Becton, Dickinson and Company Main Business
5.11.3 Becton, Dickinson and Company Chronic Pain Treatment Products, Services and Solutions
5.11.4 Becton, Dickinson and Company Chronic Pain Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 Becton, Dickinson and Company Recent Developments
5.12 Sanofi
5.12.1 Sanofi Profile
5.12.2 Sanofi Main Business
5.12.3 Sanofi Chronic Pain Treatment Products, Services and Solutions
5.12.4 Sanofi Chronic Pain Treatment Revenue (US$ Million) & (2018-2023)
5.12.5 Sanofi Recent Developments
6 North America
6.1 North America Chronic Pain Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Chronic Pain Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Chronic Pain Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Chronic Pain Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Chronic Pain Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Chronic Pain Treatment Market Dynamics
11.1 Chronic Pain Treatment Industry Trends
11.2 Chronic Pain Treatment Market Drivers
11.3 Chronic Pain Treatment Market Challenges
11.4 Chronic Pain Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
